In vivo metabolic imaging of cardiac bioenergetics in transgenic mice

Biochemical and Biophysical Research Communications

Volumn 271, Issue 1, 2000, Pages 222-228

  Omerovic, E ^a   Basetti, M ^a   Bollano, E ^a   Bohlooly, M ^a   Tornell J ^a   Isgaard, J ^a   Hjalmarson, A ^a   Soussi, B ^a   Waagstein, F ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular diseases; Growth hormone; In vivo animal models; ISIS; Magnetic resonance spectroscopy; Myocardial energy metabolism; Transgenic mice; Volume selective 31P MRS

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GROWTH HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BIOENERGY; CONTROLLED STUDY; HEART; HEART MUSCLE METABOLISM; HORMONE SYNTHESIS; HUMAN; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 0034728776     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2518     Document Type: Article

References (31)

1. Chien, K. R. (1995) Cardiac muscle diseases in genetically engineered mice: Evolution of molecular physiology. Am. J. Physiol. 269, H755-H766.
2. Doevendans, P. A., Daemen, M. J., de Muinck, E. D., and Smits, J. F. (1998) Cardiovascular phenotyping in mice. Cardiovasc. Res. 39, 34-49.
3. James, J. F., Hewett, T. E., and Robbins, J. (1998) Cardiac physiology in transgenic mice. Circ. Res. 82, 407-415.
4. Bottomley, P. A. (1994) MR spectroscopy of the human heart: The status and the challenges. Radiology 191, 593-612.
5. 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur. Heart J. 16(Suppl. O), 115-118.
6. Omerovic, E., Bollano, E., Basetti, M., Kujacic, V., Waagstein, L., Hjalmarson, Waagstein, F., and Soussi, B. (1999) Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J. Mol. Cell. Cardiol. 31, 1685-1695.
7. Tornell, J., Rymo, L., and Isaksson, O. G. (1991) Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice. Int. J. Cancer 49, 114-117.
8. Ordidge, R. J., Connelly, A., and Lohman, J. A. B. (1985) Image-selected in vivo spectroscopy (ISIS): A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 66, 283-294.
9. 2 consumption, high-energy phosphates, and substrate uptake in porcine right ventricle. Am. J. Physiol. 266, H521-H530.
10. Bottomley, P. A., Hardy, C. J., and Weiss, R. G. (1991) Correcting human heart 31P NMR spectra fo partial saturation. Evidence that saturation factors for PCr/ATP are homogenous in normal and disease states. J. Magn. Reson. 95, 341-255.
11. Bottomley, P. A. (1992) The trouble with spectroscopy papers. J. Magn. Reson. Imaging 2, 1-8.
12. de Roos, A., Doornbos, J., Luyten, P. R., Oosterwaal, L. J., van der Wall, E. E., and den Hollander, J. A. (1992) Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: Assessment with proton-decoupled P-31 MR spectroscopy. J. Magn. Reson. Imaging 2, 711-719.
13. Woodson, R. D., Torrance, J. D., Shappell, S. D., and Lenfant, C. (1970) The effect of cardiac disease on hemoglobin-oxygen binding. J. Clin. Invest. 49, 1349-1356.
14. Horn, M., Kadgien, M., Schnackerz, K., and Neubauer, S. (1994) 31P Metabolites in the blood show marked species differences. Proc. Soc. Magn. Reson. Med. 1, 318.
15. de Roos, A., and van der Wall, E. E. (1994) Evaluation of ischemic heart disease by magnetic resonance imaging and spectroscopy. Radiol. Clin. North Am. 32, 581-592.
16. 31P MRS for evaluation of cardiac energy status in the transgenic mice overexpressing growth hormone. MAGMA 6, 200.
17. 31P image-selected in vivo spectroscopy. NMR Biomed. 9, 327-332.
18. Bottomley, P. A., Herfkens, R. J., Smith, L. S., and Bashore, T. M. (1987) Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology 165, 703-707.
19. Weiss, R. G., Bottomley, P. A., Hardy, C. J., and Gerstenblith, G. (1990) Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary ar-tery disease. N. Engl. J. Med. 323, 1593-1600.
20. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86, 1810-1818.
21. Saupe, K. W., Spindler, M., Tian, R., and Ingwall, J. S. (1998) Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ. Res. 82, 898-907.
22. Spindler, M., Saupe, K. W., Christe, M. E., Sweeney, H. L., Seidman, C. E., Seidman, J. G., and Ingwall, J. S. (1998) Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest. 101, 1775-1783.
23. Dorn, G. W., 2nd, Robbins, J., Ball, N., and Walsh, R. A. (1994) Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am. J. Physiol. 267, H400-H405.
24. Iwase, M., Bishop, S. P., Uechi, M., Vatner, D. E., Shannon, R. P., Kudej, R. K., Wight, D. C., Wagner, T. E., Ishikawa, Y., Homcy, C. J., and Vatner, S. F. (1996) Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha over-expression. Circ. Res. 78, 517-524.
25. Gottshall, K. R., Hunter, J. J., Tanaka, N., Dalton, N., Becker, K. D., Ross, J., Jr., and Chien, K. R. (1997) Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc. Natl. Acad. Sci. USA 94, 4710-4715.
26. Kass, D. A., Hare, J. M., and Georgakopoulos, D. (1998) Murine cardiac function: A cautionary tail. Circ. Res. 82, 519-522.
27. Flogel, U., Decking, U. K., Godecke, A., and Schrader, J. (1999) Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: A study in endothelial NO synthase knockout mice. J. Mol. Cell. Cardiol. 31, 827-836.
28. Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., Pabst, T., Ertl, G., Hahn, D., Ingwall, J. S., and Kochsiek, K. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190-2196.
29. Wanke, R., Wolf, E., Hermanns, W., Folger, S., Buchmuller, T., and Brem, G. (1992) The GH-transgenic mouse as an experimental model for growth research: Clinical and pathological studies. Horm. Res. 37, 74-87.
30. Brem, G., Wanke, R., Wolf, E., Buchmuller, T., Muller, M., Brenig, B., and Hermanns, W. (1989) Multiple consequences of human growth hormone expression in transgenic mice. Mol. Biol. Med. 6, 531-547.
31. 31P MR spectroscopy of human blood and serum: Results from volunteers and patients with congestive heart failure and diabetes mellitus. Proc. Annu. Meeting Soc. Magn. Reson. Med., 1198.